Bacterial vaginosis primary prevention

Jump to navigation Jump to search

Sexually transmitted diseases Main Page

Vaginitis Main Page

Bacterial vaginosis Microchapters


Patient Information


Historical Perspective



Differentiating Bacterial vaginosis from other Diseases

Epidemiology and Demographics

Risk Factors


Natural History, Complications and Prognosis


Amsel Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Other Imaging Findings

Other Diagnostic Studies


Medical Therapy


Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Bacterial vaginosis primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides


American Roentgen Ray Society Images of Bacterial vaginosis primary prevention

All Images
Echo & Ultrasound
CT Images

Ongoing Trials at Clinical

US National Guidelines Clearinghouse

NICE Guidance

FDA on Bacterial vaginosis primary prevention

CDC on Bacterial vaginosis primary prevention

Bacterial vaginosis primary prevention in the news

Blogs on Bacterial vaginosis primary prevention

Directions to Hospitals Treating Bacterial vaginosis

Risk calculators and risk factors for Bacterial vaginosis primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [2]


Basic effective measures for the primary prevention of bacterial vaginosis include practicing abstinent, limit the number of sex partner, avoid douching and use of condoms and estrogen-containing contraceptives.[1][2][3]

Primary Prevention

Most cases of bacterial vaginosis occur in sexually active women between the ages of 15 and 44, especially after contact with a new partner. Condoms may provide some protection. Although BV appears to be associated with sexual activity, there is no clear evidence of sexual transmission.[4] Basic effective measures for the primary prevention of bacterial vaginosis infection include:[1][2][3]


  1. 1.0 1.1 Ness RB, Hillier SL, Richter HE, Soper DE, Stamm C, McGregor J; et al. (2002). "Douching in relation to bacterial vaginosis, lactobacilli, and facultative bacteria in the vagina". Obstet Gynecol. 100 (4): 765. PMID 12383547.
  2. 2.0 2.1 Bradshaw CS, Walker SM, Vodstrcil LA, Bilardi JE, Law M, Hocking JS; et al. (2014). "The influence of behaviors and relationships on the vaginal microbiota of women and their female partners: the WOW Health Study". J Infect Dis. 209 (10): 1562–72. doi:10.1093/infdis/jit664. PMID 24285846.
  3. 3.0 3.1 Bradshaw CS, Vodstrcil LA, Hocking JS, Law M, Pirotta M, Garland SM; et al. (2013). "Recurrence of bacterial vaginosis is significantly associated with posttreatment sexual activities and hormonal contraceptive use". Clin Infect Dis. 56 (6): 777–86. doi:10.1093/cid/cis1030. PMID 23243173.
  4. Bradshaw CS, Morton AN, Hocking J; et al. (2006). "High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence". J Infect Dis. 193 (11): 1478&ndash, 86.

Template:WS Template:WH